Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of rituximab in Mexican patients with Multiple Sclerosis-A single-center retrospective study.
Bribiesca-Contreras E, García-Estrada C, Gómez-Figueroa E, Zertuche-Ortuño L, Rodríguez-Rivas R, Marcín-Sierra M, Delgado-Niño M, Rivas-Alonso V, Corona-Vázquez T, Flores-Rivera J. Bribiesca-Contreras E, et al. Among authors: rivas alonso v. Mult Scler Relat Disord. 2022 Feb;58:103485. doi: 10.1016/j.msard.2021.103485. Epub 2022 Jan 4. Mult Scler Relat Disord. 2022. PMID: 35042092
Perceived discrimination in patients with multiple sclerosis and depressive symptomatology.
Ochoa-Morales A, Fresan-Orellana A, Hernández-Mojica T, Jara-Prado A, Corona-Vázquez T, Flores-Rivera JJ, Rito-García CY, Rivas-Alonso V, Guerrero-Camacho JL, Dávila-Ortiz de Montellano DJ. Ochoa-Morales A, et al. Mult Scler Relat Disord. 2021 Feb;48:102705. doi: 10.1016/j.msard.2020.102705. Epub 2020 Dec 28. Mult Scler Relat Disord. 2021. PMID: 33383366
Socioeconomic status and access to multiple sclerosis treatment in Mexico.
Gómez-Figueroa E, de Saráchaga AJ, García-Estrada C, Casallas-Vanegas A, Delgado-García G, Garcia-Martinez P, Zabala-Angeles I, Marcin-Sierra M, Moreno-Torres P, Corona-Vázquez T, Rivas-Alonso V, Flores-Rivera J. Gómez-Figueroa E, et al. Mult Scler Relat Disord. 2021 Jul;52:102967. doi: 10.1016/j.msard.2021.102967. Epub 2021 Apr 20. Mult Scler Relat Disord. 2021. PMID: 33934010
Clinical experience of plasmapheresis for neuromyelitis optica patients in Mexico.
Gómez-Figueroa E, Alvarado-Bolaños A, García-Estrada C, Zabala-Ángeles I, Sánchez-Rosales N, Bribiesca-Contreras E, García-Alvarez G, Montes-Pérez Y, Ramos-Vega E, Casallas-Vanegas A, Carrillo-Loza K, Corona-Vázquez T, Rivas-Alonso V, Flores-Rivera J. Gómez-Figueroa E, et al. Mult Scler Relat Disord. 2021 Jul;52:103022. doi: 10.1016/j.msard.2021.103022. Epub 2021 May 15. Mult Scler Relat Disord. 2021. PMID: 34034213
Quality of life in patients with multiple sclerosis and its association with depressive symptoms and physical disability.
Ochoa-Morales A, Hernández-Mojica T, Paz-Rodríguez F, Jara-Prado A, Trujillo-De Los Santos Z, Sánchez-Guzmán MA, Guerrero-Camacho JL, Corona-Vázquez T, Flores J, Camacho-Molina A, Rivas-Alonso V, Dávila-Ortiz de Montellano DJ. Ochoa-Morales A, et al. Mult Scler Relat Disord. 2019 Nov;36:101386. doi: 10.1016/j.msard.2019.101386. Epub 2019 Sep 9. Mult Scler Relat Disord. 2019. PMID: 31520986
Effect of rituximab on disease activity in latin American patients with anti-aquaporin-4 (+) neuromyelitis optica spectrum disorder.
Gomez-Figueroa E, Noriega-Morales G, Casallas-Vanegas A, Zabala-Angeles I, Garcia-Estrada C, Neri D, Sarachaga AJ, Rivas-Alonso V, Corona-Vazquez T, Flores-Rivera J. Gomez-Figueroa E, et al. Clin Neurol Neurosurg. 2020 Sep;196:106007. doi: 10.1016/j.clineuro.2020.106007. Epub 2020 Jun 9. Clin Neurol Neurosurg. 2020. PMID: 32559706
Acute optic nerve lesions in first-ever NMOSD-related optic neuritis using conventional brain MRI: A Latin American multicenter study.
Carnero Contentti E, Delgado-García G, López PA, Criniti J, Pettinicchi JP, Correa-Díaz EP, Soto de Castillo I, Daccach Marques V, Tkachuk V, Cristiano E, Serva Braga Diéguez G, Dos Santos AC, Castillo MC, Patrucco L, Álvarez Pucha MO, Miño Zambrano JE, Gómez-Figueroa E, Rivas-Alonso V, Flores-Rivera J, Caride A, Rojas JI. Carnero Contentti E, et al. Mult Scler Relat Disord. 2020 Nov;46:102558. doi: 10.1016/j.msard.2020.102558. Epub 2020 Oct 2. Mult Scler Relat Disord. 2020. PMID: 33032052
Rituximab efficacy at different initial and maintenance doses in neuromyelitis optica spectrum disorder: Experience from a national health institute in México.
Casallas-Vanegas A, Gomez-Figueroa E, de Saráchaga AJ, Zabala-Angeles I, García-Estrada C, Salado-Burbano JC, DiazGranados-Palacio MC, Corona-Vázquez T, de Jesús Flores-Rivera J, Rivas-Alonso V. Casallas-Vanegas A, et al. J Neurol Sci. 2020 Dec 15;419:117204. doi: 10.1016/j.jns.2020.117204. Epub 2020 Oct 22. J Neurol Sci. 2020. PMID: 33161302
29 results